Concepedia

Grégory Catteau

GC

13

Publications

1.2K

Citations

13

H-Index

2010

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

Stiftung Juliusspital

GlaxoSmithKline (United States)

Uppsala University Hospital

Uppsala University

Grégory Catteau is an author at GlaxoSmithKline (Belgium) specializing in medicine, vaccination, and human papillomavirus vaccines.

Top concepts

Publications per year

2010–2020

13

Publications

13

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

Paulo Naud, Cecília Roteli-Martins, Newton Sérgio de Carvalho et al. · Human Vaccines & Immunotherapeutics · 2014 · 245 citations · Full text

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule

Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson et al. · Human Vaccines · 2011 · 194 citations · Full text

Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial

Allan Hildesheim, Sholom Wacholder, Grégory Catteau et al. · Vaccine · 2014 · 130 citations · Full text

Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults

Roman Chlíbek, Karlis Pauksens, Lars Rombo et al. · Vaccine · 2015 · 121 citations · Full text

Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: <i>Post‐hoc</i> analysis from a randomized controlled trial

Suzanne M. Garland, Jorma Paavonen, Unnop Jaisamrarn et al. · International Journal of Cancer · 2016 · 100 citations · Full text

Rows per page

1–5 of 13